Concepedia

Richard T. Lostritto

RT

Statistics

Publications

12

Citations

1.2K

H-Index

10

Active since

1988

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

University of Connecticut

Richard T. Lostritto is an author at Center for Drug Evaluation and Research specializing in pharmacology, medicine, and oncology.

Publications per year

1988–2017

12

Publications

12

United States Food and Drug Administration Drug Approval Summary

Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2004 · 500 citations

Medicine, Oncology, Pharmacology +15

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

Peter Bross, Robert C. Kane, Ann T. Farrell et al. · Clinical Cancer Research · 2004 · 340 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pemetrexed in Malignant Pleural Mesothelioma

Maitreyee Hazarika, Robert M. White, Brian Booth et al. · Clinical Cancer Research · 2005 · 110 citations · Full text

Medicine, Oncology, Pharmacology +15

Fulvestrant in postmenopausal women with advanced breast cancer.

Peter Bross, Amy Baird, Gang Chen et al. · PubMed · 2003 · 52 citations

Medicine, Oncology, Pharmacology +16

Eribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Use of a “Physician's Choice” Control Arm in a Randomized Approval Trial

Martha Donoghue, Steven J. Lemery, Weishi Yuan et al. · Clinical Cancer Research · 2012 · 46 citations

Medicine, Oncology, Pharmacotherapy +14

1–5 of 12